Reports Q1 revenue $4.33M, consensus $4.31M. The company reiterated that it believes its adjusted EBITDA breakeven run rate is $15.5M of SaaS ARR and that it expects to achieve this run rate during the second half of fiscal 2024. Due to the continued unpredictability of timing related to the closing of new contracts, the company has not provided more specific guidance related to the timing of bookings. “As a result of executing contract implementations while expanding our footprint with new and existing clients we expect to achieve ongoing adjusted EBITDA profitability during the second half of this fiscal year,” stated Ben Stilwill, President and Chief Executive Officer, of the Company. “Furthermore, we continue to improve the impact of our existing solutions for clients by incorporating novel AI techniques furthering our mission to ensure our nation’s health systems are paid for all of the care they provide.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STRM:
- Streamline Health® To Report Fiscal First Quarter 2024 Financial Performance
- Streamline Health® Announces New RevID™ Contract with 400-Bed Health System
- Streamline Health announces new RevID contract with 400-bed health system
- Streamline Health Solutions Reveals Executive Chairman’s Compensation Plan
- Streamline Health files to sell 564.7K shares of common stock for holders